US Patent Number

10,512,641

Publication Date

12-24-2019

Abstract

Described herein are methods for treating cancer in a subject in need thereof by administering chloroquine, or a salt or prodrug thereof, optionally with another agent that promotes Par-4 production to induce prostate apoptosis response-4 (Par-4) production by host cells, particularly non-cancerous host cells, to promote apoptosis in cancer cells, including androgen insensitive prostate cancer cells.

Assignees

The University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

15/576,366

Filing Date

6-1-2016

Share

COinS